Rhythm Biosciences Ltd. (AU:RHY) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Rhythm Biosciences Ltd has successfully raised $3.5 million through a strong share placement, priced at $0.10 per share, to further develop and commercialize its ColoSTAT® Multiplex colorectal cancer test. The placement attracted significant interest from new institutional and sophisticated investors, reflecting confidence in the company’s innovative cancer diagnostics technology. The funds will support the finalization of the test kit, clinical validation, and expansion of their R&D pipeline.
For further insights into AU:RHY stock, check out TipRanks’ Stock Analysis page.